Health Care
featured
You might survive going to the emergency room — but the "surprise" bill you get later could be a real killer. » Read More
By: Dan Mangan
One-third of U.S. adults reported not getting recommended health care and not going to the doctor when sick because of the costs. » Read More |
By: Dan Mangan
The tally represents a slight uptick in health plan selections compared with the same time period last year. » Read More |
By: Robert Ferris
Zika can survive in a highly contagious form outside a host, such as on a table or counter. But common chemicals can kill it. » Read More |
More
Chinese scientists are first to inject a person with gene-edited cells using the CRISPR technique. This could be America's biotech Sputnik.
One anti-anxiety drug, Ativan, had an average unit cost increase of a stunning 1,264 percent between 2014 and 2015 for Medicaid.
Scientists are using "minibrains" to understand how diseases and drugs interact with a normal human brain.
As of now, 4.6 million people in California received health coverage funded by the Affordable Care Act.
Retirees will pay more for this medical insurance program in the new year. Find out how much you'll pay.
"Most Americans hate their insurance and they hate the health-care system. It's unaffordable and it needs to be fixed," Aetna's Mark Bertolini says.
President-elect Donald Trump's proposal to overhaul Medicaid funding could force states to raise taxes or cut spending.
Whether Donald Trump repeals Obamacare or simply fixes it, either way, the system needs restructuring, Centene chief Michael Neidorff tells CNBC.
Valeant shares were down 22 percent on Tuesday, but Wells Fargo's David Maris says the company still has some time to right the ship.
Senior Research Analyst David Amsellem says, "We had never viewed the previous ranges as credible."
Valeant Pharmaceuticals reported an 11 percent fall in quarterly revenue due to faltering sales, and cut its full-year profit and revenue forecasts.
A U.S. Senate committee urged regulators to launch a probe into whether EpiPen maker Mylan broke the law by preventing schools from purchasing competing allergy treatments.
More than $125 million has been spent over an initiative to bar state agencies from paying more for drugs than the Veterans Affairs Department pays.
Just 4 percent of people can define all four terms that determine how much they would pay out of pocket for health services.
Drugmaker Mylan may have overcharged hospitals that serve significant numbers of poor people for lifesaving anti-allergy devices.
Pharmaceutical stocks have been under pressure, but certain companies are doing things right, former Medtronic CEO Bill George says.
Contact Health Care
-
CNBC NEWSLETTERS
Get the best of CNBC in your inbox
Get these newsletters delivered to your inbox, and more info about about our products and service. Privacy Policy.▲Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.
Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.
